Renaissance Technologies’s Pulse Biosciences PLSE Stock Holding History

Renaissance Technologies’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-67,800	Closed	-$1.09M	–	3813
2025 Q1	$1.09M	Buy	+67,800	New	+$1.26M	﹤0.01%	2370
2024 Q4	–	Sell	-22,800	Closed	-$400K	–	3831
2024 Q3	$400K	Sell	22,800 -22,600	-50%	-$385K	﹤0.01%	2879
2024 Q2	$508K	Sell	45,400 -16,000	-26%	-$151K	﹤0.01%	2683
2024 Q1	$535K	Buy	+61,400	New	+$564K	﹤0.01%	2834
2023 Q4	–	Sell	-71,500	Closed	-$288K	–	4043
2023 Q3	$288K	Buy	+71,500	New	+$444K	﹤0.01%	2944
2022 Q2	–	Sell	-77,824	Closed	-$378K	–	4492
2022 Q1	$378K	Buy	+77,824	New	+$637K	﹤0.01%	3361
2021 Q3	–	Sell	-39,852	Closed	-$654K	–	3755
2021 Q2	$654K	Buy	+39,852	New	+$759K	﹤0.01%	2854

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Renaissance Technologies's PLSE Position: Q2 2025 in Review

Renaissance Technologies sold out of Pulse Biosciences (PLSE) in Q2 2025, closing a stake of 67,800 shares — an estimated $1.09M sold.

Renaissance Technologies first reported a position in PLSE in Q2 2021 and held it in 7 quarters. The position peaked at $1.09M in Q1 2025. 86 funds tracked by Wall St. Rank hold PLSE as of Q2 2025.

Renaissance Technologies reported no remaining Pulse Biosciences position as of Q2 2025 after selling out during the quarter.
Renaissance Technologies sold 67,800 Pulse Biosciences shares in Q2 2025, an estimated $1.09M.
Renaissance Technologies first reported a position in Pulse Biosciences in Q2 2021 and held it in 7 quarters.
Renaissance Technologies's Pulse Biosciences position peaked at $1.09M in Q1 2025.
86 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2025.

Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.